The results of these experiments demonstrate that all cancer-associated PBRM1-BD4 missense variants impair the ability of full-length PBRM1 to increase the expression of its target genes and do not affect the expression of non-PBRM1 target genes like YWHAZ (Fig. 6C). This evidence concerns the gene PBRM1 and cancer.